{Reference Type}: Case Reports
{Title}: The first case of SMARCA4-deficient sarcoma of stomach.
{Author}: Ota T;Ishikawa T;Yasuda R;Yasuda T;Okayama T;Inoue K;Dohi O;Yoshida N;Kamada K;Uchiyama K;Takagi T;Konishi H;Naito Y;Matsuyama K;Yamaguchi T;Ootsuka K;Yoshida A;Kishimoto M;Itoh Y;
{Journal}: Clin J Gastroenterol
{Volume}: 15
{Issue}: 3
{Year}: Jun 2022
暂无{DOI}: 10.1007/s12328-022-01606-8
{Abstract}: SMARCA4-deficient sarcoma was first reported in the chest and recently in the uterus, but not in the stomach. Here, we present a patient diagnosed with SMARCA4-deficient sarcoma of the stomach, using histochemistry. An emergency operation was performed due to perforation of the tumor. However, one month after the operation, two nodes recurred, and six cycles of combination chemotherapy consisting of adriamycin and ifosfamide were administered. The combination chemotherapy showed a remarkable effect, and complete remission was achieved. The patient was alive without recurrence after 48-month follow-up. SMARCA4-deficient sarcoma is an exceedingly rare tumor with an extremely poor therapeutic response to anticancer drugs. Herein, we present the first case of SMARCA4-deficient sarcoma of the stomach, where a complete response to chemotherapy was achieved.